Blood preservation with STBS - gateway to personalized medicine

First patent in our portfolio

Publication of Spark-Tech patent application in China.

On May 2019 Spark-Tech signed grant agreament with The National Centre for Research and Development to develop Spark-Tech Biobanking System (STBS). Value of this project is 11 300 248,31 PLN (2,6 mln EURO) with EU contribution of 8 836 058,10 PLN (2,2 mln EURO). Project will be conducted from June 2019 to May 2021. https://www.ncbr.gov.pl/fileadmin/POIR/3_1.1.1_2018_MSP_Seal_of_Excellence/lista_rankingowa_listopad_2018_SOE.pdf Spark-Tube…
Przeczytaj więcej

Spark-Tech Biobanking System (STBS) and its components pictured in red cross are to streamline diagnostic effort. Figure illustrates that specimen collection (green frame) can be done simply in various conditions. Later STBS in automated fashion separates and preserves patient samples which can be send to analyses remotely (blue frame).    

Spark-Tech signed an agreement to lead implementation of National project awarded to Katarzyna Marzec PhD within Lider program http://jcet.eu/new_en/research/#012 . Spark-Tech will be responsible for IPR and commercial aspects of project results.

Publication of Spark-Tech patent application in United States

Publication of Spark-Tech patent application in China

SPARK-TECH presented innovative Spark-Tech Biobanking System (STBS) at 2018 BIO International Convention in Boston (US).

SPARK-TECH is a commercialization partner in Nationally funded project „Diagnostics of the biochemical alterations in packed human red blood cells (PRBCs) with the use of vibrational spectroscopy”. Project aims to develop spectroscopic methodology for the Raman (RS) and Infrared (IR) diagnostic quality assessment of the pre-transfusion RBCs. Project was awarded by NCBiR to Katarzyna Marzec Ph.D.…
Przeczytaj więcej

Today, we received information, that our company brand SPARK-TECH has been registered as the European Union trademark by the European Union Office Intellectual Property Office.